Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine : A case report
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved..
We report a case of a Japanese man with severe rhabdomyolysis and multiple thrombosis of arterioles after the first dose of mRNA-1273 vaccine. He developed rapidly progressive rhabdomyolysis and infarctions of multiple organs. Antiplatelet factor 4 antibody test was negative. Despite the intensive supportive care, including aggressive fluid administration, hemodialysis, administration of anticoagulants, high-dose steroid, and eculizumab, the patient ultimately died of multiple organ failure. Autopsy revealed multiple thrombosis in the arterioles and organ necrosis. Low serum complements and C3 deposition in the renal glomeruli detected by immunofluorescence suggested a possible immune-mediated mechanism. To our knowledge, this is the first case report of rhabdomyolysis and multiple thrombosis of the arterioles as an adverse event following COVID-19 vaccination.
Errataetall: |
CommentIn: Int J Infect Dis. 2022 Sep;122:443. - PMID 35760378 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:117 |
---|---|
Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 117(2022) vom: 15. Apr., Seite 322-325 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kamura, Yuya [VerfasserIn] |
---|
Links: |
---|
Themen: |
2019-nCoV Vaccine mRNA-1273 |
---|
Anmerkungen: |
Date Completed 30.03.2022 Date Revised 10.03.2023 published: Print-Electronic CommentIn: Int J Infect Dis. 2022 Sep;122:443. - PMID 35760378 Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijid.2022.02.031 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337211248 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337211248 | ||
003 | DE-627 | ||
005 | 20231225233906.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2022.02.031 |2 doi | |
028 | 5 | 2 | |a pubmed24n1123.xml |
035 | |a (DE-627)NLM337211248 | ||
035 | |a (NLM)35189339 | ||
035 | |a (PII)S1201-9712(22)00107-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kamura, Yuya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine |b A case report |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.03.2022 | ||
500 | |a Date Revised 10.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Int J Infect Dis. 2022 Sep;122:443. - PMID 35760378 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a We report a case of a Japanese man with severe rhabdomyolysis and multiple thrombosis of arterioles after the first dose of mRNA-1273 vaccine. He developed rapidly progressive rhabdomyolysis and infarctions of multiple organs. Antiplatelet factor 4 antibody test was negative. Despite the intensive supportive care, including aggressive fluid administration, hemodialysis, administration of anticoagulants, high-dose steroid, and eculizumab, the patient ultimately died of multiple organ failure. Autopsy revealed multiple thrombosis in the arterioles and organ necrosis. Low serum complements and C3 deposition in the renal glomeruli detected by immunofluorescence suggested a possible immune-mediated mechanism. To our knowledge, this is the first case report of rhabdomyolysis and multiple thrombosis of the arterioles as an adverse event following COVID-19 vaccination | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a complemental activation | |
650 | 4 | |a mRNA-1273 | |
650 | 4 | |a rhabdomyolysis | |
650 | 4 | |a thrombosis | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
650 | 7 | |a 2019-nCoV Vaccine mRNA-1273 |2 NLM | |
650 | 7 | |a EPK39PL4R4 |2 NLM | |
700 | 1 | |a Terao, Toshiki |e verfasserin |4 aut | |
700 | 1 | |a Akao, Satoshi |e verfasserin |4 aut | |
700 | 1 | |a Kono, Yumi |e verfasserin |4 aut | |
700 | 1 | |a Honma, Koichi |e verfasserin |4 aut | |
700 | 1 | |a Matsue, Kosei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 117(2022) vom: 15. Apr., Seite 322-325 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
773 | 1 | 8 | |g volume:117 |g year:2022 |g day:15 |g month:04 |g pages:322-325 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2022.02.031 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 117 |j 2022 |b 15 |c 04 |h 322-325 |